Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mod Pathol ; 26(3): 456-63, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23174939

ABSTRACT

Most gastrointestinal stromal tumors (GISTs) harbor oncogenic mutations in KIT or platelet-derived growth factor receptor-α. However, a small subset of GISTs lacks such mutations and is termed 'wild-type GISTs'. Germline mutation in any of the subunits of succinate dehydrogenase (SDH) predisposes individuals to hereditary paragangliomas and pheochromocytomas. However, germline mutations of the genes encoding SDH subunits A, B, C or D (SDHA, SDHB, SDHC or SDHD; collectively SDHx) are also identified in GISTs. SDHA and SDHB immunohistochemistry are reliable techniques to identify pheochromocytomas and paragangliomas with mutations in SDHA, SDHB, SDHC and SDHD. In this study, we investigated if SDHA immunohistochemistry could also identify SDHA-mutated GISTs. Twenty-four adult wild-type GISTs and nine pediatric/adolescent wild-type GISTs were analyzed with SDHB, and where this was negative, then with SDHA immunohistochemistry. If SDHA immunohistochemistry was negative, sequencing analysis of the entire SDHA coding sequence was performed. All nine pediatric/adolescent GISTs and seven adult wild-type GISTs were negative for SDHB immunohistochemistry. One pediatric GIST and three SDHB-immunonegative adult wild-type GISTs were negative for SDHA immunohistochemistry. In all four SDHA-negative GISTs, a germline SDHA c.91C>T transition was found leading to a nonsense p.Arg31X mutation. Our results demonstrate that SDHA immunohistochemistry on GISTs can identify the presence of an SDHA germline mutation. Identifying GISTs with deficient SDH activity warrants additional genetic testing, evaluation and follow-up for inherited disorders and paragangliomas.


Subject(s)
Biomarkers, Tumor , Electron Transport Complex II , Gastrointestinal Stromal Tumors/enzymology , Germ-Line Mutation , Adolescent , Adult , Age Factors , Aged , Biomarkers, Tumor/genetics , Biomarkers, Tumor/immunology , Child , DNA Mutational Analysis , Electron Transport Complex II/genetics , Electron Transport Complex II/immunology , Gastrointestinal Stromal Tumors/genetics , Gastrointestinal Stromal Tumors/immunology , Gastrointestinal Stromal Tumors/pathology , Genetic Predisposition to Disease , Humans , Immunohistochemistry , Male , Middle Aged , Phenotype , Young Adult
2.
J Bioenerg Biomembr ; 43(6): 651-61, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22081211

ABSTRACT

Trypanosoma cruzi is a hemoflagellate protozoan that causes Chagas' disease. The life cycle of T. cruzi is complex and involves different evolutive forms that have to encounter different environmental conditions provided by the host. Herein, we performed a functional assessment of mitochondrial metabolism in the following two distinct evolutive forms of T. cruzi: the insect stage epimastigote and the freshly isolated bloodstream trypomastigote. We observed that in comparison to epimastigotes, bloodstream trypomastigotes facilitate the entry of electrons into the electron transport chain by increasing complex II-III activity. Interestingly, cytochrome c oxidase (CCO) activity and the expression of CCO subunit IV were reduced in bloodstream forms, creating an "electron bottleneck" that favored an increase in electron leakage and H(2)O(2) formation. We propose that the oxidative preconditioning provided by this mechanism confers protection to bloodstream trypomastigotes against the host immune system. In this scenario, mitochondrial remodeling during the T. cruzi life cycle may represent a key metabolic adaptation for parasite survival in different hosts.


Subject(s)
Electron Transport Complex III/metabolism , Electron Transport Complex II/metabolism , Life Cycle Stages/physiology , Mitochondria/metabolism , Protozoan Proteins/metabolism , Trypanosoma cruzi/metabolism , Adaptation, Physiological/physiology , Animals , Chagas Disease/immunology , Chagas Disease/metabolism , Chagas Disease/parasitology , Electron Transport Complex II/immunology , Electron Transport Complex III/immunology , Humans , Hydrogen Peroxide/immunology , Hydrogen Peroxide/metabolism , Mitochondria/immunology , Protozoan Proteins/immunology , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/immunology
3.
Biopolymers ; 96(2): 207-21, 2011.
Article in English | MEDLINE | ID: mdl-20564035

ABSTRACT

Mitochondria are the major source of reactive oxygen species. Both complex I and complex II mediate O2*- production in mitochondria and host reactive protein thiols. To explore the functions of the specific domains involved in the redox modifications of complexes I and II, various peptide-based antibodies were generated against these complexes, and their inhibitory effects were subsequently measured. The redox domains involved in S-glutathionylation and nitration, as well as the binding 2011. motif of the iron-sulfur cluster (N1a) of the complexes I and II were utilized to design B-cell epitopes for generating antibodies. The effect of antibody binding on enzyme-mediated O2*- generation was measured by EPR spin trapping. Binding of either antibody AbGSCA206 or AbGSCB367 against glutathione (GS)-binding domain to complex I inhibit its O2*- generation, but does not affect electron transfer efficiency. Binding of antibody (Ab24N1a) against the binding motif of N1a to complex I modestly suppresses both O2*- generation and electron transfer efficiency. Binding of either antibody Ab75 or Ab24 against nonredox domain decreases electron leakage production. In complex II, binding of antibody AbGSC90 against GS-binding domain to complex II marginally decreases both O2*- generation and electron transfer activity. Binding of antibody AbY142 to complex II against the nitrated domain modestly inhibits electron leakage, but does not affect the electron transfer activity of complex II. In conclusion, mediation of O2*- generation by complexes I and II can be regulated by specific redox and nonredox domains.


Subject(s)
Electron Transport Complex II , Electron Transport Complex I , Mitochondria, Heart , Mitochondrial Proteins , Peptides , Amino Acid Motifs , Animals , Cattle , Electron Transport Complex I/antagonists & inhibitors , Electron Transport Complex I/chemistry , Electron Transport Complex I/immunology , Electron Transport Complex I/metabolism , Electron Transport Complex II/antagonists & inhibitors , Electron Transport Complex II/chemistry , Electron Transport Complex II/immunology , Electron Transport Complex II/metabolism , Female , Mitochondria, Heart/chemistry , Mitochondria, Heart/immunology , Mitochondria, Heart/metabolism , Mitochondrial Proteins/antagonists & inhibitors , Mitochondrial Proteins/chemistry , Mitochondrial Proteins/immunology , Mitochondrial Proteins/metabolism , Peptides/chemistry , Peptides/immunology , Peptides/metabolism , Protein Structure, Tertiary , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...